ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 166 filers reported holding ALLAKOS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,462 | -47.9% | 5,490 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $23,936 | +49.6% | 5,490 | +100.4% | 0.00% | 0.0% |
Q1 2022 | $16,000 | -40.7% | 2,740 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $27,000 | -90.7% | 2,740 | 0.0% | 0.00% | -90.9% |
Q3 2021 | $290,000 | +23.9% | 2,740 | 0.0% | 0.01% | +37.5% |
Q2 2021 | $234,000 | -4.5% | 2,740 | +28.5% | 0.01% | -11.1% |
Q1 2021 | $245,000 | -18.6% | 2,133 | -0.8% | 0.01% | -35.7% |
Q4 2020 | $301,000 | +72.0% | 2,151 | 0.0% | 0.01% | +75.0% |
Q3 2020 | $175,000 | +12.9% | 2,151 | 0.0% | 0.01% | +14.3% |
Q2 2020 | $155,000 | +103.9% | 2,151 | +25.7% | 0.01% | +75.0% |
Q1 2020 | $76,000 | -53.4% | 1,711 | 0.0% | 0.00% | -42.9% |
Q4 2019 | $163,000 | +28.3% | 1,711 | +5.7% | 0.01% | +16.7% |
Q3 2019 | $127,000 | +98.4% | 1,619 | +9.1% | 0.01% | +100.0% |
Q2 2019 | $64,000 | +36.2% | 1,484 | +26.7% | 0.00% | +50.0% |
Q1 2019 | $47,000 | +30.6% | 1,171 | +71.7% | 0.00% | 0.0% |
Q4 2018 | $36,000 | +16.1% | 682 | 0.0% | 0.00% | +100.0% |
Q3 2018 | $31,000 | – | 682 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |